AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca u.S. Retail Sales — Pharmacies and Drug Stores, Seasonally Adjusted ($M) ($M)
FRED / U.S. Census Bureau (MRTSSM44611USS)
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | U.S. Retail Sales — Pharmacies and Drug Stores, Seasonally Adjusted ($M) ($M) | Year on year | Source |
|---|
Breakdown
What makes up u.s. retail sales — pharmacies and drug stores, seasonally adjusted ($m)
Cite this data
StockData. (2026). AstraZeneca U.S. Retail Sales — Pharmacies and Drug Stores, Seasonally Adjusted ($M) ($M), quarterly [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/fred_retail_pharm_sa
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.